New Delhi: Council of Scientific & Industrial Research (CSIR), and Laxai Life Sciences Pvt. Ltd. Hyderabad, have been given the regulatory approval by DCGI to undertake a two-arm phase-II clinical trial to assess the safety and efficacy of the dr
The Council of Scientific and Industrial Research (CSIR) will undertake a two-arm phase-II clinical trial to assess the safety and efficacy of the drug Colchicine for the treatment of Covid-19 patients.Colchicine is used for treating gout and .
The Drugs Controller General of India has approved the Phase-II trial of Colchicine, which can help Covid-19 patients with co-morbidities related to heart and also for their faster recovery.